Drug Type Recombinant protein |
Synonyms Recombinant interleukin-18 binding protein (Yeda Pharma), Tadekinig Alfa, r-hIL-18BP (Yeda Pharma) |
Target |
Action inhibitors |
Mechanism IL-18 inhibitors(Interleukin 18 inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
RegulationOrphan Drug (European Union) |

| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Crohn Disease | Phase 2 | - | - | |
| Crohn Disease | Phase 2 | - | - | |
| Psoriasis | Phase 2 | - | - | |
| Psoriasis | Phase 2 | - | - | |
| Rheumatoid Arthritis | Phase 2 | - | - | |
| Rheumatoid Arthritis | Phase 2 | - | - |






